We are excited to announce our participation at the upcoming AD/PD™ 2024 International Conference on Alzheimer’s and Parkinson’s Diseases and related neurological disorders. This esteemed conference brings together leading international experts to focus on driving successful collaborations among academia and industry in the field of neurodegenerative diseases.
The event is scheduled from March 5th to March 9th, 2024 – in the lively city of Lisbon. It is also offered as a hybrid event.

Cutting-edge science and top speakers in the field

The AD/PD™ Conference serves as a global platform where the brightest minds gather to explore the latest research, clinical trials, and treatments for Alzheimer’s and Parkinson’s. Here, experts will share insights, discuss clinical trials, and unveil novel therapeutic approaches.

Leading international experts get together to focus on driving successful collaborations among academia and industry in the field of neurodegenerative diseases and it serves as a vital forum for collaboration, innovation, and progress.

Our revolutionary approach:

At the heart of Noselab’s participation lies our groundbreaking diagnostic platform based on nasal-derived CSF (nCSF). Recently unveiled at the 2023 Boston CTAD Conference, our platform offers paradigm shift in the diagnosis and management of neurodegenerative diseases. By leveraging cutting-edge technology, Noselab aims to provide early and accurate diagnoses, empowering clinicians, and patients alike. Learn more about our participation at the 2023 Boston CTAD Conference here.
Our unveiling has attracted a lot of attention, and the AD/PD™ conference represents an ideal stage for further discussions and collaborations.

Join us on this journey

We invite all conference attendees (onsite or digital) and everyone interested to join us on this journey to enable earlier and better diagnostics, understanding, and treatment of neurodegenerative diseases. Together, let’s pave the way toward a brighter future for those affected by neurodegenerative diseases. Whether you’re a researcher, clinician, or industry professional: your presence matters.

Let’s make connections and collaborations, exchange knowledge, and ignite progress.


Lisbon awaits, and so do the next milestones in the research of neurodegenerative diseases.

Where to find us

Booth: #19


Poster Board Number: #0235

Title: Non-invasive detection of AD biomarkers for differentiation of AD in cognitively impaired patients

Presentation of the poster on March 6  – 7